SVP, Regulatory Affairs
Sara joined Cogent in March 2021 and is responsible for the company’s global regulatory affairs strategy and operations. Sara is an accomplished regulatory professional with 19 years of global regulatory and drug development experience across a variety of therapeutic areas. She has successfully led regulatory and cross-functional teams supporting development programs from first-in-human trials through commercialization, including global marketing approvals for Mozobil® (plerixafor) and Kanuma® (sebelipase alfa). Prior to Cogent, Sara held regulatory leadership positions at Unum, Alexion, Takeda Oncology, and Sanofi Genzyme. She received a Bachelor of Arts degree in Biology from Colby College. In her spare time, Sara loves cooking and skiing with her family.